Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
letter
. 2016 Oct 14;113(41):688–689. doi: 10.3238/arztebl.2016.0688b

Correspondence (letter to the editor): Confusing Information

Andreas Stang *
PMCID: PMC5143795  PMID: 27839536

Neis et al. cite findings from a randomized study on the impact of laparoscopic and laparotomy-based myomectomy on pain medication use at 72 h post-procedure (1): „85% of patients (17/20) did not require pain medication 72 hours after laparoscopic surgery compared with 15% (3/20) of patients after abdominal myomectomy (relative risk reduction [RR] 5.7; 95% confidence interval [95% CI] 2.0; 16.4)“ (1). These figures are confusing for three reasons:

First, Lethaby and Vollenhoven (2) were incorrectly cited, since they reported a relative risk (RR) (not a relative risk reduction). The RR of 5.7 is calculated by dividing 85% (no pain medication use, laparotomy group) by 15% (no pain medication use, laparoscopy group). Rather than reflecting a risk reduction, an RR of 5.7 reflects an increased risk, in this case the „risk“ (or better put: the probability) of taking no pain medication. In simple terms: the probability of not requiring further pain medication in the laparoscopy group is 5.7 times that of the laparotomy group.

Second, selecting a negative result, „not used,“ rather than a positive result, „used,“ complicates risk communication.

Third, the requirement of postoperative pain medication depends to a crucial extent on the time interval since surgery. Mais et al. reported pain medication use on postoperative day 2 (recorded between 7:00 and 11:00), whereby they called the day of surgery day 0. Thus, the percentages given by Mais et al. do not refer to „72 hours“ postoperatively, but rather 37–52 hours postoperatively (thus more like 48 hours on average), assuming that surgery was performed on day 0 between 7:00 and 18:00 (Mais et al. provided no data on the time of surgery).

Footnotes

Conflict of interest statement

The author states that no conflicts of interest exist.

References

  • 1.Neis KJ, Zubke W, Fehr M, Römer T, Tamussino K, Nothacker M. Clinical practice guideline: Hysterectomy for benign uterine disease. Dtsch Arztebl Int. 2016;113:242–249. doi: 10.3238/arztebl.2016.0242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas) BMJ Clin Evid. 2011 pii: 0814. [PMC free article] [PubMed] [Google Scholar]
  • 3.Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis GB. Laparoscopic versus abdominal myomectomy: a prospective randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol. 1996;174:654–658. doi: 10.1016/s0002-9378(96)70445-3. [DOI] [PubMed] [Google Scholar]

Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES